๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib

โœ Scribed by Yoshimura, Naruo; Kudoh, Shinzoh; Kimura, Tatsuo; Mitsuoka, Shigeki; Matsuura, Kuniomi; Hirata, Kazuto; Matsui, Kaoru; Negoro, Shunichi; Nakagawa, Kazuhiko; Fukuoka, Masahiro


Book ID
119319307
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
149 KB
Volume
51
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES